Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $721 thousand versus the consensus estimate of $1.9 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.